| Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection DS Khoury, D Cromer, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... Nature medicine 27 (7), 1205-1211, 2021 | 3505 | 2021 |
| Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection C Phetsouphanh, DR Darley, DB Wilson, A Howe, C Munier, SK Patel, ... Nature immunology 23 (2), 210-216, 2022 | 666 | 2022 |
| Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis D Cromer, M Steain, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... The Lancet Microbe 3 (1), e52-e61, 2022 | 484 | 2022 |
| Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 JA Juno, HX Tan, WS Lee, A Reynaldi, HG Kelly, K Wragg, R Esterbauer, ... Nature medicine 26 (9), 1428-1434, 2020 | 440 | 2020 |
| Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 AK Wheatley, JA Juno, JJ Wang, KJ Selva, A Reynaldi, HX Tan, WS Lee, ... Nature communications 12 (1), 1162, 2021 | 357 | 2021 |
| Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection D Cromer, JA Juno, D Khoury, A Reynaldi, AK Wheatley, SJ Kent, ... Nature Reviews Immunology 21 (6), 395-404, 2021 | 264 | 2021 |
| Cytotoxic CD4 T cells—Friend or foe during viral infection? JA Juno, D Van Bockel, SJ Kent, AD Kelleher, JJ Zaunders, CML Munier Frontiers in immunology 8, 19, 2017 | 205 | 2017 |
| Invariant NKT cells: regulation and function during viral infection JA Juno, Y Keynan, KR Fowke PLoS Pathog 8 (8), e1002838, 2012 | 201 | 2012 |
| Suboptimal SARS-CoV-2− specific CD8+ T cell response associated with the prominent HLA-A* 02: 01 phenotype JR Habel, THO Nguyen, CE van de Sandt, JA Juno, P Chaurasia, ... Proceedings of the National Academy of Sciences 117 (39), 24384-24391, 2020 | 188 | 2020 |
| A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers J Lajoie, J Juno, A Burgener, S Rahman, K Mogk, C Wachihi, J Mwanjewe, ... Mucosal immunology 5 (3), 277-287, 2012 | 167 | 2012 |
| Systems serology detects functionally distinct coronavirus antibody features in children and elderly KJ Selva, CE Van De Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, ... Nature communications 12 (1), 2037, 2021 | 133 | 2021 |
| Integrated immune dynamics define correlates of COVID-19 severity and antibody responses M Koutsakos, LC Rowntree, L Hensen, BY Chua, CE Van De Sandt, ... Cell Reports Medicine 2 (3), 2021 | 130 | 2021 |
| Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine Y Ju, WS Lee, EH Pilkington, HG Kelly, S Li, KJ Selva, KM Wragg, ... ACS nano 16 (8), 11769-11780, 2022 | 122 | 2022 |
| CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity THO Nguyen, LC Rowntree, J Petersen, BY Chua, L Hensen, L Kedzierski, ... Immunity 54 (5), 1066-1082. e5, 2021 | 117 | 2021 |
| Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences SK Patel, JA Juno, WS Lee, KM Wragg, PM Hogarth, SJ Kent, LM Burrell European Respiratory Journal 57 (5), 2021 | 115 | 2021 |
| Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? SJ Kent, DS Khoury, A Reynaldi, JA Juno, AK Wheatley, E Stadler, ... Nature Reviews Immunology 22 (6), 387-397, 2022 | 108 | 2022 |
| Immune imprinting and SARS-CoV-2 vaccine design AK Wheatley, A Fox, HX Tan, JA Juno, MP Davenport, K Subbarao, ... Trends in immunology 42 (11), 956-959, 2021 | 82 | 2021 |
| High HIV risk in a cohort of male sex workers from Nairobi, Kenya LR McKinnon, G Gakii, JA Juno, P Izulla, J Munyao, N Ireri, CW Kariuki, ... Sexually transmitted infections 90 (3), 237-242, 2014 | 82 | 2014 |
| Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem HX Tan, S Jegaskanda, JA Juno, R Esterbauer, J Wong, HG Kelly, Y Liu, ... The Journal of clinical investigation 129 (2), 850-862, 2019 | 81 | 2019 |
| Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques HX Tan, JA Juno, WS Lee, I Barber-Axthelm, HG Kelly, KM Wragg, ... Nature communications 12 (1), 1403, 2021 | 74 | 2021 |
